SciClone Strengthens its Presence in China with NovaMed Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 4 (Table of Contents)
Published: 30 Apr-2011
DOI: 10.3833/pdr.v2011.i4.1466 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
SciClone Pharmaceuticals has significantly broadened its commercial footprint in China by purchasing the Shanghai-based speciality pharmaceutical company NovaMed Pharmaceuticals for approximately US$62 M upfront in cash and shares...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS